Search for the Molecular Causes of Diabetic Embryopathy
Search for the Molecular Causes of Diabetic Embryopathy
批准号:
6783161
负责人:
MARY R LOEKEN
金额:
$40.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-08-01 至 2009-02-28
关键词:
CHO cellsapoptosischemical stabilitycongenital nervous system disorderdevelopmental neurobiologyembryogenesisembryonic stem cellgene expressiongenetic regulationgenetically modified animalsgestational diabetes mellituslaboratory mousemammalian embryologymolecular pathologyneural plate /tubep53 gene /proteinprotein biosynthesisprotein protein interactionreporter genesterminal nick end labelingtranscription factortransfection
中文摘要
描述(由申请人提供):神经管是脊椎动物胚胎发育过程中最早形成的结构之一;它形成大脑和脊髓发育的支架,因此,神经管的正确建立对于中枢神经系统的正常发育至关重要。Pax 3编码一种DNA结合转录因子,其在神经管形成早期表达,并且对于神经管在吻侧和尾侧神经孔处的闭合以及对于背板的适当背侧化是必需的。我们发现母体糖尿病抑制糖尿病小鼠胚胎中Pax 3的表达,并增加神经管缺陷(NTD)。NTD是女性糖尿病患者后代中最常见的先天性畸形之一。因此,了解母体糖尿病如何干扰Pax 3的表达,以及Pax 3的生产不足如何导致NTD,对于了解这些缺陷如何发生非常重要。最近,我们发现,p53缺陷拯救胚胎与非功能性Pax 3等位基因从NTD,和稳态p53蛋白水平降低,在胚胎表达野生型Pax 3相比,胚胎表达非功能性Pax 3。基于这些发现,我们推测Pax 3通过抑制p53的合成或稳定性来抑制p53依赖的凋亡,从而指导神经管发育。我们将通过确定Pax 3是否在神经管融合前和融合后神经管背侧化期间阻止神经褶皱中的细胞周期停滞和随后的p53依赖性凋亡来测试该假设(目的1),以及确定p53合成或稳定性是否被Pax 3抑制,并研究p53合成或稳定性受损的发生机制(目的2)。目标1将使用敲除小鼠系进行,其中Pax 3基因已用报告基因标记,使得Pax 3表达细胞可在神经管形成期间进行命运作图,所述敲除小鼠系已与p53敲除小鼠杂交。目的2将使用表达或不表达Pax 3和p53的细胞系来研究p53的合成或稳定性。这项研究将大大推进我们的知识如何关闭和神经管的背侧化的调节,并提供新的信息的分子机制,糖尿病妊娠导致NTD。
英文摘要
DESCRIPTION (provided by applicant): The neural tube is one of the earliest structures to form during vertebrate embryogenesis; it forms the scaffolding upon which the brain and spinal cord will develop, therefore, proper establishment of the neural tube is critical for normal development of the central nervous system. Pax3 encodes a DNA-binding transcription factor that is expressed early during neural tube formation and is essential for neural tube closure at the rostral and caudal neuropores, and for proper dorsalization of the alar plate. We have found that maternal diabetes inhibits expression of Pax3 in embryos of diabetic mice and increases neural tube defects (NTD). NTD are among the most common of the congenital malformations in the offspring of women with diabetes. Therefore, understanding how maternal diabetes disturbs the expression of Pax3, and how insufficient production of Pax3 leads to NTD, is important to understand how these defects occur. Recently, we showed that p53 deficiency rescues embryos with nonfunctional Pax3 alleles from NTD, and that steady state p53 protein levels are reduced in embryos expressing wild type Pax3 compared to embryos expressing nonfunctional Pax3. Based on these findings we hypothesize that Pax3 directs neural tube development by suppressing p53-dependent apoptosis by inhibiting p53 synthesis or stability. We will test this hypothesis in this proposal by determining whether Pax3 prevents cell cycle arrest and subsequent p53-dependent apoptosis in the neural folds prior to neural tube fusion, and during dorsalization of the neural tube following fusion (Aim 1), and determining whether p53 synthesis or stability is inhibited by Pax3 and investigating the mechanisms by which impaired synthesis or stability of p53 occurs (Aim 2). Aim 1 will be performed using knockout mouse lines, in which the Pax3 gene has been tagged with a reporter gene so that Pax3- expressing cells can be fate mapped during neural tube formation, that have been crossed with p53 knockout mice. Aim 2 will be performed using cells lines that express Pax3 or not, and p53 to study p53 synthesis or stability. This research will significantly advance our knowledge of how closure and dorsalization of the neural tube is regulated, and provide new information on the molecular mechanisms by which diabetic pregnancy causes NTD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Slc2a2/Glut2 in Embryo and Stem Cell Metabolism, Self-Renewal, and Pathways Involved in Diabetic Embryopathy
-
批准号:8913593
-
项目类别:
-
资助金额:$53.31万
-
财政年份:2015
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:8004610
-
项目类别:
-
资助金额:$10.53万
-
财政年份:2009
-
负责人:MARY R LOEKEN
-
依托单位:
EFFECT OF HYPERGLYCEMIA ON NEURALATING MOUSE EMBRYOS
-
批准号:7953823
-
项目类别:
-
资助金额:$0.56万
-
财政年份:2008
-
负责人:MARY R LOEKEN
-
依托单位:
EFFECT OF HYPERGLYCEMIA ON NEURALATING MOUSE EMBRYOS
-
批准号:6979993
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2003
-
负责人:MARY R LOEKEN
-
依托单位:
MOLECULAR REGULATION: EMBYROGENESIS BY METABOLIC STRESS
-
批准号:6643452
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
MOLECULAR REGULATION: EMBYROGENESIS BY METABOLIC STRESS
-
批准号:6381856
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
MOLECULAR REGULATION: EMBYROGENESIS BY METABOLIC STRESS
-
批准号:6524305
-
项目类别:
-
资助金额:$24.98万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
MOLECULAR REGULATION: EMBYROGENESIS BY METABOLIC STRESS
-
批准号:6190733
-
项目类别:
-
资助金额:$24.31万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:8442927
-
项目类别:
-
资助金额:$34.63万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:7578310
-
项目类别:
-
资助金额:$35.32万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:8205876
-
项目类别:
-
资助金额:$40.65万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:7779375
-
项目类别:
-
资助金额:$36.09万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:8638944
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:8290477
-
项目类别:
-
资助金额:$35.78万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:7367913
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:7188566
-
项目类别:
-
资助金额:$35.5万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
Embryonic Gene Expression During Diabetic Embryopathy
-
批准号:7049723
-
项目类别:
-
资助金额:$34.54万
-
财政年份:2000
-
负责人:MARY R LOEKEN
-
依托单位:
SEARCH FOR THE MOLECULAR CAUSES OF DIABETIC EMBRYOPATHY
-
批准号:6523667
-
项目类别:
-
资助金额:$28.5万
-
财政年份:1998
-
负责人:MARY R LOEKEN
-
依托单位:
SEARCH FOR THE MOLECULAR CAUSES OF DIABETIC EMBRYOPATHY
-
批准号:2620475
-
项目类别:
-
资助金额:$26.29万
-
财政年份:1998
-
负责人:MARY R LOEKEN
-
依托单位:
Search for the Molecular Causes of Diabetic Embryopathy
-
批准号:8027758
-
项目类别:
-
资助金额:$34.88万
-
财政年份:1998
-
负责人:MARY R LOEKEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: